GleamWall
中文EN

LFMD LifeMD, Inc.

Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 948320 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.6%
TTM net income YoY95.6%
TTM EPS YoY91.2%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—

Margins

Gross margin84.1%
Operating margin-17.9%
Net margin-0.3%
FCF margin-7.5%
EBITDA margin-17.2%

Returns

ROE-125.9%
ROA-0.7%
ROIC (approx.)—
Asset turnover2.26x

Leverage & solvency

Liabilities / assets100.9%
Debt / equity—
Current ratio0.80x
Interest coverage92.33x

Cash quality & payout

Operating cash flow / net income23.16x
Accruals ratio15.5%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$44.63M$47.28M$50.16M$7.08M$47.73M$49.02M$50.89M$5.49M
Cost of revenue$8.25M$5.28M$5.93M$4.23M$7.06M$6.84M$8.14M$9.43M
Gross profit$36.38M$42.00M$44.24M$2.85M$40.67M$42.18M$42.75M-$1.32M
SG&A expense$14.65M$13.65M$15.18M$6.73M$13.80M$14.44M$14.34M$6.79M
Operating income-$4.47M-$7.13M-$8.93M-$6.22M-$3.13M-$2.35M-$1.18M-$5.97M
Interest expense$3,212-$45,660-$56,476-$190,791$260,621$660,787$463,638$614,074
Pretax income-$4.47M-$7.08M-$8.87M-$6.03M-$4.54M-$3.01M-$1.65M-$6.58M
Income tax———-$123,413$31,823——$169,477
Net income-$4.47M-$7.08M-$8.87M$19.96M-$3.89M-$1.62M-$183,778-$4.94M
EBITDA-$4.17M-$6.84M-$8.64M-$5.97M-$2.87M-$2.17M-$1.03M-$5.80M
EPS (basic)-0.11-0.16-0.20—-0.10-0.05-0.02—
EPS (diluted)-0.11-0.16-0.20—-0.10-0.05-0.02—
Weighted avg. shares (diluted)48.18M47.79M47.34M—46.16M44.40M43.14M—
Balance sheet
Cash & equivalents$21.92M$25.14M$34.48M$36.79M$20.95M$33.01M$31.95M$32.65M
Receivables$13.25M$11.26M$9.86M$2.49M$9.24M$7.33M$10.19M$10.46M
Inventory$10.35M$2.96M$3.18M$2.77M$3.43M$3.25M$2.97M$2.80M
Current assets$49.26M$42.08M$51.70M$45.01M$41.09M$49.03M$49.97M$52.37M
PP&E, net$1.91M$2.04M$2.26M$2.44M$2.58M$2.05M$1.44M$1.44M
Intangibles$166,583$198,500$230,417$262,334$1.56M$1.83M$1.79M$53,336
Total assets$66.29M$59.89M$70.12M$63.59M$65.98M$73.56M$73.61M$76.10M
Current liabilities$61.70M$46.61M$49.59M$39.58M$56.66M$63.53M$60.90M$67.40M
Long-term debt—————$15.90M——
Total debt—————$15.90M——
Total liabilities$66.86M$51.93M$55.09M$45.26M$62.62M$73.18M$74.01M$83.65M
Shareholders' equity-$579,655$7.97M$15.04M$18.33M$1.31M-$1.78M-$2.33M-$9.08M
Net debt—————-$17.11M——
Shares outstanding48.26M47.82M47.53M46.66M46.58M45.04M43.53M42.19M
Cash flow statement
Operating cash flow-$949,634-$6.93M$444,624-$3.28M-$147,136$8.64M$3.07M$1.07M
Capital expenditure$170,728$67,825$105,178$155,454$785,748$776,670$117,545$225,410
Free cash flow-$1.12M-$6.99M$339,446-$3.44M-$932,884$7.86M$2.95M$847,891
Investing cash flow-$1.49M-$1.63M-$2.06M$17.07M-$3.59M-$3.70M-$2.87M-$2.72M
Financing cash flow-$776,563-$776,562-$696,043-$788,562-$8.70M-$3.10M-$812,563-$934,903
Depreciation & amortization$301,000$293,000$289,458$255,955$253,000$176,000$155,361$166,278
Stock-based compensation$1.68M$790,112$1.45M$2.66M$3.20M$2.09M$2.55M$3.10M
Dividends paid$776,563$776,562$776,563$776,562$776,563$776,562$776,563$776,562
Share buybacks————$270,000———

Free plan shows the latest 8 periods; Pro shows all 59 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.